ASHPOfficial

Episoder

• 
  ASHP Midyear Speaker Series 2026: The Incredible Incretinsꟷ Diana Isaacs PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP and Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP 20.10.2026 6min

  In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Hannah Post, education director at ASHP, as she interviews Diana Isaacs, endocrine clinical pharmacy specialist at Cleveland Clinic Diabetes Center, and Christie Schumacher, professor of pharmacy practice and director of the PGY2 Ambulatory Care Residency Program at Midwestern University College of Pharmacy, Downers Grove Campus, to discuss their upcoming session: The Incredible Incretins: Expanded Indications and the Latest Breakthroughs.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Practice Journeys: You Start a New Role. Now What? Laying Your Personal Development Foundation 19.10.2026 26min

  In this episode, participants share their own stories — the successes, missteps, and lessons they wish they'd known — while offering practical strategies to help pharmacists and pharmacy technicians navigate their first 90 days with confidence. They then explore how embracing continuous professional development can transform each career transition into an opportunity for lifelong growth and professional fulfillment.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Clinical Conversations (CE): GLP Practice Insights: GLP-1 Receptor Agonists and Bone Mineral Density (CE) 17.10.2026 15min

  This activity explores emerging evidence on the relationship between GLP-1 receptor agonists therapy and bone mineral density. As the use of these agents expands across chronic disease states, pharmacists must understand their potential impact on bone health to support comprehensive patient care and risk mitigation.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Live with ASHP: ASHP Midyear Speaker Series 2026: Transforming Care Through Next-Generation Therapeuticsꟷ Heidi Trinkman, PharmD, BCOP, and Emilie Aschenbrenner, PharmD, BCOP 16.10.2026 7min

  In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Hannah Post, education director at ASHP, as she interviews Heidi Trinkman, advanced therapeutics program manager at Cook Children's Health Care System, Emilie Aschenbrenner, pharmacy program lead for cell and gene therapy and bone marrow transplant at Froedtert Hospital, and Wendy Galbraith, Clinical Associate Professor at the University of Oklahoma Health Sciences Center, to discuss their upcoming session: Transforming Care Through Next-Generation Therapeutics: Theranostics, Cell and Gene Therapies, and Pharmacogenomics.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Pharmacy Leadership: Beyond the Technology: A Pharmacy Leader’s Guide to Leading AI Transformation 16.10.2026 31min

  As artificial intelligence becomes embedded across health systems, pharmacy leaders face a new challenge: leading organizational change to seamlessly adopt and integrate it. Join pharmacy executives and innovation leaders as they discuss managing workforce expectations, establishing strong AI governance, measuring meaningful outcomes, and scaling successful initiatives to drive lasting value across the pharmacy enterprise.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Clinical Conversations: ASHP Guidelines Spotlight: ASHP Guidelines on Pharmacist Involvement in HIV Care 15.10.2026 43min

  Join us for a deep dive with the authors of the new ASHP Guidelines on Pharmacist Involvement in HIV Care, where we will unpack its contents. This episode discusses the evolving role of pharmacists in HIV prevention, treatment, and management, from expanding access to HIV testing and PrEP/PEP services to optimizing antiretroviral therapy and addressing social determinants of health. We’ll explore how pharmacists can improve patient outcomes and advocate for policy changes that deepen our impact. Tune in to learn what’s new, what’s next, and how these guidelines can transform HIV care across all practice settings. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Live with ASHP: ASHP Midyear Speaker Series: Futurecasting Your Departmentꟷ Anthony Scott, PharmD, MBA, FASHP, and Katherine Miller, PharmD, MHA, CPEL, DPLA, FASHP, FKCHP 14.10.2026 8min

  In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Anthony Scott, director, pharmacy operations and account management at Cardinal Health, and Katherine Miller, senior director acute care pharmacy & clinical nutrition at The University of Kansas Health System, to discuss their upcoming session: Futurecasting Your Department: Strategic Succession Planning in an Era of Rapid Change. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Hot Topics in Pharmacy: Women's Health: Antithrombotic Stewardship from Menstruation to Menopause 13.10.2026 36min

  Women experience changes in thrombotic and bleeding risk across every stage of life, yet these considerations are often underrecognized in antithrombotic management. This episode explores how antithrombotic stewardship can optimize care from menstruation through menopause, highlighting practical strategies for managing heavy menstrual bleeding, contraception, pregnancy considerations, perimenopause, and hormone therapy while balancing thrombosis and bleeding risks. Listeners will gain evidence-based approaches to individualized patient care, improve interdisciplinary collaboration, and identify stewardship opportunities to enhance safety, outcomes, and health equity for patients receiving anticoagulant and antithrombotic therapy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Insights & Connections: Policy Week in Focus - Priorities, Progress, and What’s Ahead 12.10.2026 19min

  Advocacy is a driving force behind our strategic priorities and this year’s Policy Week brought those priorities directly to Capitol Hill. ASHP Executive Vice President and CEO Sam Calabrese and Chief Advocacy Officer and Vice President of Government Relations Tom Kraus reflect on this year’s Policy Week, discussing the key policy priorities that shaped the week, conversations with lawmakers and congressional staff, and the momentum surrounding pharmacy’s advocacy priorities. From meaningful engagement on the Hill to the collective voice of our members, we’ll explore how Policy Week is helping turn our advocacy priorities into action. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Educator Essentials: Less Hands on Deck: Handing a Co-Resident Departure 12.10.2026 35min

  This episode discusses resources and offers support for residents that have experienced a co-resident’s departure from the residency program. Discussion will involve how to re-balance and carry the mental load if residents are expected to fill in the gap.  Listeners will hear discussions from residency program directors and past residents that experienced the departure of a co-resident.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Clinical Conversations (CE): Navigating the Maze of Medication Access: Introduction to Medication Access, Medication Access Dashboards,  & Manufacturer Free Drug Patient Assistance Programs 10.10.2026 34min

  This podcast explores medication access options for uninsured and underinsured patients, including manufacturer patient assistance programs, copay cards, nonprofit foundations, discount programs, and federal assistance. It also highlights how advanced pharmacy technicians lead medication access programs that improve adherence, reduce costs, streamline workflows, and drive measurable quality and financial outcomes.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Hot Topics in Pharmacy Practice: Off the Clock, On the Line: Managing After-Hours Investigational Drug Trials 07.10.2026 21min

  Clinical trials in acute and emergency care settings may require immediate pharmacy support in the evenings, nights and weekends when staff with specialized expertise are not on site.  In this episode, two experienced clinical research pharmacists highlight the challenges of after-hours investigational drug dispensing and detail practical strategies and creative techniques for managing these time-sensitive studies.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Live with ASHP: ASHP Midyear Speaker Series: From Overlooked to Approvedꟷ Thomas Johnson, PharmD, MBA, BCCCP, BCPS, CPEL, FACHE, FASHP, FCCM, FSDSHP 07.10.2026 7min

  In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Thomas Johnson, vice president of diagnostic and therapeutic services at Avera Health, to discuss his upcoming session: From Overlooked to Approved: The Power of Clarity with C-Suite Resource Requests.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Clinical Conversations (CE): Vaccine-Preventable Diseases: RSV (CE) 06.10.2026 12min

  Respiratory Syncytial Virus (RSV) is the most common cause of bronchiolitis, the most common lower respiratory tract infection in infants less than 12 months old. The recent availability of a maternal vaccination and a neonatal/infant immunoglobulin injection provide the chance for a dramatic change in the rates of infection. Unfortunately, an increasing vaccination hesitancy in the United States threatens the potential of these efforts. After completing this episode, learners will be able to discuss the presentation and management of an infant with RSV and review the vaccination processes to prevent transmission of RSV. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Clinical Conversations (CE): Buprenorphine for Chronic Pain: Your Questions, Our Real-World Insights and Strategies for Success 05.10.2026 39min

  In this episode, a panel of expert clinicians tackle some common and challenging unanswered questions surrounding the use of buprenorphine for chronic pain. Drawing from real-world practice, they explore strategies for initiation, risk mitigation, perioperative management, and formulation selection- while addressing practical barriers and off-label approaches. Listen in for evidenced-informed insights that bridge the gap between clinical uncertainty and confident prescribing.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Live with ASHP: ASHP Midyear Speaker Series 2026: From Curious to Confidentꟷ Michael Wolcott, PharmD, PhD 05.10.2026 6min

  In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Michael Wolcott, assistant dean for student affairs and associate professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, to discuss his upcoming session: From Curious to Confident: A Practical Primer for Preceptors Interested in Artificial Intelligence. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  AJHP Voices: National trends in prescription drug expenditures and projections for 2026 01.10.2026 39min

  In this podcast, Eric Tichy and Denise Scarpelli discuss the AJHP Special Feature "National trends in prescription drug expenditures and projections for 2026” with host and AJHP Editor in Chief Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Live with ASHP: ASHP Pharmacy Leaders Conference Speaker Series: The Pharmacy Advantageꟷ Katherine S. DeSanctis, PharmD, MS 29.09.2026 7min

  In anticipation of the 2026 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews pharmacy director Katherine S. DeSanctis to discuss her upcoming session: The Pharmacy Advantage: Aligning the New Five Rights to Drive Throughput and Measurable Value.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Clinical Conversations (CE): IV Ketamine in Pain Management (CE) 26.09.2026 16min

  Although ketamine was initially utilized as a general anesthetic, it has also been applied to treat both acute and chronic pain. This CE podcast will discuss IV ketamine across the perioperative setting, emergency medicine, and palliative care.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
• 
  Well-being and Resiliency in Pharmacy Practice: De-stigmatizing Mental Health in Credentialing and Licensing Processes 25.09.2026 34min

  State boards of pharmacy play a critical role in protecting the public, but they also have an imperative to support the well-being of the professionals they regulate. In this episode, we explore the Dr. Lorna Breen Foundation’s Wellbeing First Champion Challenge and its efforts to remove barriers that prevent healthcare workers from seeking mental health care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.